Literature DB >> 31860338

Is there a role for arcing techniques in proton therapy?

Alejandro Carabe-Fernandez1, Alejandro Bertolet-Reina1, Ilias Karagounis1, Kiet Huynh1, Roger G Dale2.   

Abstract

Proton arc therapy (PAT) has been proposed as a possible evolution for proton therapy. This commentary uses dosimetric and cancer risk evaluations from earlier studies to compare PAT with intensity modulated proton therapy. It is concluded that, although PAT may not produce better physical dose distributions than intensity modulated proton therapy, the radiobiological considerations associated with particular PAT techniques could offer the possibility of an increased therapeutic index.

Entities:  

Mesh:

Year:  2020        PMID: 31860338      PMCID: PMC7066964          DOI: 10.1259/bjr.20190469

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  14 in total

Review 1.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

2.  Linear energy transfer painting with proton therapy: a means of reducing radiation doses with equivalent clinical effectiveness.

Authors:  Marcus Fager; Iuliana Toma-Dasu; Maura Kirk; Derek Dolney; Eric S Diffenderfer; Neha Vapiwala; Alejandro Carabe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

3.  Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates.

Authors:  Steven van de Water; Sairos Safai; Jacobus M Schippers; Damien C Weber; Antony J Lomax
Journal:  Acta Oncol       Date:  2019-06-26       Impact factor: 4.089

4.  Have we reached proton beam therapy dosimetric limitations? - A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer.

Authors:  Xuanfeng Ding; Xiaoqiang Li; An Qin; Jun Zhou; Di Yan; Craig Stevens; Daniel Krauss; Peyman Kabolizdeh
Journal:  Acta Oncol       Date:  2017-08-03       Impact factor: 4.089

5.  Range optimization for mono- and bi-energetic proton modulated arc therapy with pencil beam scanning.

Authors:  Daniel Sanchez-Parcerisa; Maura Kirk; Marcus Fager; Brendan Burgdorf; Malorie Stowe; Tim Solberg; Alejandro Carabe
Journal:  Phys Med Biol       Date:  2016-10-14       Impact factor: 3.609

6.  Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines.

Authors:  E Shaw; R Kline; M Gillin; L Souhami; A Hirschfeld; R Dinapoli; L Martin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-12-01       Impact factor: 7.038

7.  Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.

Authors:  Xuanfeng Ding; Xiaoqiang Li; J Michele Zhang; Peyman Kabolizadeh; Craig Stevens; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-07       Impact factor: 7.038

8.  Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy.

Authors:  E Sengbusch; A Pérez-Andújar; P M DeLuca; T R Mackie
Journal:  Med Phys       Date:  2009-02       Impact factor: 4.071

9.  Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.

Authors:  Joao Seco; Guan Gu; Tiago Marcelos; Hanne Kooy; Henning Willers
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-09-01       Impact factor: 7.038

10.  A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy.

Authors:  Jeong-Eun Rah; Gwe-Ya Kim; Do Hoon Oh; Tae Hyun Kim; Jong Won Kim; Dae Yong Kim; Sung Yong Park; Dongho Shin
Journal:  Radiat Oncol       Date:  2016-10-21       Impact factor: 3.481

View more
  7 in total

1.  Proton therapy special feature: introductory editorial.

Authors:  Kathryn D Held; Antony J Lomax; Esther G C Troost
Journal:  Br J Radiol       Date:  2020-03       Impact factor: 3.039

2.  Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.

Authors:  Stewart Mein; Thomas Tessonnier; Benedikt Kopp; Semi Harrabi; Amir Abdollahi; Jürgen Debus; Thomas Haberer; Andrea Mairani
Journal:  Adv Radiat Oncol       Date:  2021-02-04

Review 3.  Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless Rooms.

Authors:  Alejandro Mazal; Juan Antonio Vera Sanchez; Daniel Sanchez-Parcerisa; Jose Manuel Udias; Samuel España; Victor Sanchez-Tembleque; Luis Mario Fraile; Paloma Bragado; Alvaro Gutierrez-Uzquiza; Nuria Gordillo; Gaston Garcia; Juan Castro Novais; Juan Maria Perez Moreno; Lina Mayorga Ortiz; Amaia Ilundain Idoate; Marta Cremades Sendino; Carme Ares; Raymond Miralbell; Niek Schreuder
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

Review 4.  Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.

Authors:  Julia M Pakela; Antje Knopf; Lei Dong; Antoni Rucinski; Wei Zou
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

5.  Proton Minibeam Radiation Therapy and Arc Therapy: Proof of Concept of a Winning Alliance.

Authors:  Ramon Ortiz; Ludovic De Marzi; Yolanda Prezado
Journal:  Cancers (Basel)       Date:  2021-12-27       Impact factor: 6.639

Review 6.  Value of carbon-ion radiotherapy for early stage non-small cell lung cancer.

Authors:  Hanguang Ruan; Juan Xiong
Journal:  Clin Transl Radiat Oncol       Date:  2022-06-14

Review 7.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.